International Stem Cell Corp (ISCO) Releases Quarterly Earnings Results, Hits Estimates
International Stem Cell Corp (NASDAQ:ISCO) released its earnings data on Tuesday. The company reported ($0.01) earnings per share for the quarter, meeting the analysts’ consensus estimate of ($0.01), Stock Ratings Network.com reports.
Shares of International Stem Cell Corp (NASDAQ:ISCO) traded up 0.09% on Tuesday, hitting $0.1115. 105,350 shares of the company’s stock traded hands. International Stem Cell Corp has a 52 week low of $0.06 and a 52 week high of $0.30. The stock has a 50-day moving average of $0.09 and a 200-day moving average of $0.16. The company’s market cap is $17.7 million.
In other International Stem Cell Corp news, major shareholder Ruslan Semechkin purchased 1,000,000 shares of the stock in a transaction dated Wednesday, August 6th. The shares were purchased at an average price of $0.10 per share, for a total transaction of $100,000.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Large shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.
International Stem Cell Corporation is a biotechnology company. The Company is focused on therapeutic biomedical research and cosmeceutical products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.